Lista de obras - Marina Noris - Dominio Público Uruguay

ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established

artículo científico publicado en 2003

ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy ⬇️

artículo científico publicado el 3 de junio de 2013

Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection

artículo científico publicado en 2006

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

artículo científico publicado en 2011

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome

scientific article published on 07 March 2019

Are HUS and TTP genetically determined? ⬇️

artículo científico publicado el 1 de abril de 1998

Atypical aHUS: State of the art.

artículo científico publicado en 2015

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

artículo científico publicado en 2016

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

artículo científico publicado en 2010

Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation

scientific article published on 24 September 2019

C3 glomerulopathy - understanding a rare complement-driven renal disease

artículo científico publicado en 2019

C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial

artículo científico publicado en 2019

Challenges in Understanding Acute Postinfectious Glomerulonephritis: Are Anti-Factor B Autoantibodies the Answer?

scientific article published on 06 March 2020

Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome

artículo científico publicado en 2007

Combined kidney and liver transplantation for familial haemolytic uraemic syndrome

artículo científico publicado en 2002

Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells

artículo científico publicado en 2005

DnIKK2-Transfected Dendritic Cells Induce a Novel Population of Inducible Nitric Oxide Synthase???Expressing CD4+CD25??? Cells with Tolerogenic Properties

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

artículo científico publicado en 2014

Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation

scientific article published on 01 June 2019

Effect of a novel immunosuppressant, ST1959, on the immune system and renal allograft survival in rats.

artículo científico publicado en 2005

Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation

artículo científico publicado en 2002

Effect of seliciclib (CYC202, R-roscovitine) on lymphocyte alloreactivity and acute kidney allograft rejection in rat.

artículo científico publicado en 2008

Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury

Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival.

artículo científico publicado en 2017

Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome

artículo científico publicado en 2017

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

artículo científico publicado en 2006

Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association

artículo científico publicado en 2019

Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells

artículo científico publicado en 2007

Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation

artículo científico publicado en 2005

Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function

artículo científico publicado en 2017

Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura

artículo científico publicado en 2016

Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).

artículo científico publicado en 2006

Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes

scientific article published on 26 July 2019

Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome

artículo científico publicado en 2006

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.

artículo científico publicado en 2013

Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion

artículo científico publicado en 2005

Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis

artículo científico publicado en 2017

Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)?

artículo científico publicado en 2017

Klotho in acute kidney injury: biomarker, therapy, or a bit of both? ⬇️

artículo científico publicado el 1 de diciembre de 2010

L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species

artículo científico publicado en 2004

MYO1E mutations and childhood familial focal segmental glomerulosclerosis

artículo científico publicado en 2011

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

artículo científico publicado en 2008

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

artículo científico publicado en 2013

More about Factor H Autoantibodies in Membranous Nephropathy

artículo científico publicado en 2019

Mutations in FN1 cause glomerulopathy with fibronectin deposits.

artículo científico publicado en 2008

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background

artículo científico publicado en 2005

Overview of complement activation and regulation

artículo científico publicado en 2013

Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension.

artículo científico publicado en 2008

Prolonged cold ischemia accelerates cellular and humoral chronic rejection in a rat model of kidney allotransplantation ⬇️

artículo científico publicado el 13 de enero de 2012

Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides

artículo científico publicado en 2008

Rabbit anti-rat thymocyte immunoglobulin preserves renal function during ischemia/reperfusion injury in rat kidney transplantation

Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS

article

Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs

artículo científico publicado en 2007

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

artículo científico publicado en 2010

Report of the First World Transplant Congress

article

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

artículo científico publicado en 2012

Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome

artículo científico publicado en 2007

Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.

artículo científico publicado en 2007

Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

artículo científico publicado en 2018

Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both?

scientific article published on 01 July 2019

The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome

artículo científico publicado en 2008

The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models

artículo científico publicado en 2007

The role of complement in C3 glomerulopathy

artículo científico publicado en 2015

The role of vasoactive molecules of endothelial origin in the pathophysiology of normal pregnancy and pregnancy-induced hypertension

Thrombotic Microangiopathies

Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes

artículo científico publicado en 2015

Transplantation-Induced Ischemia-Reperfusion Injury Modulates Antigen Presentation by Donor Renal CD11c+F4/80+ Macrophages through IL-1R8 Regulation

artículo científico publicado en 2020

Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN

Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity

artículo científico publicado en 2012

Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy

artículo científico publicado en 2004

Where next with atypical hemolytic uremic syndrome?

artículo científico publicado en 2007

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

artículo científico publicado en 2002

Lista de obras de Marina Noris

ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established

ADAMTS13 Predicts Renal and Cardiovascular Events in Type 2 Diabetic Patients and Response to Therapy ⬇️

Adeno-associated virus-mediated CTLA4Ig gene transfer protects MHC-mismatched renal allografts from chronic rejection

Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis

An Ex Vivo Test of Complement Activation on Endothelium for Individualized Eculizumab Therapy in Hemolytic Uremic Syndrome

Are HUS and TTP genetically determined? ⬇️

Atypical aHUS: State of the art.

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation

C3 glomerulopathy - understanding a rare complement-driven renal disease

C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical Trial

Challenges in Understanding Acute Postinfectious Glomerulonephritis: Are Anti-Factor B Autoantibodies the Answer?

Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome

Combined kidney and liver transplantation for familial haemolytic uraemic syndrome

Dendritic cells genetically engineered with adenoviral vector encoding dnIKK2 induce the formation of potent CD4+ T-regulatory cells

DnIKK2-Transfected Dendritic Cells Induce a Novel Population of Inducible Nitric Oxide Synthase???Expressing CD4+CD25??? Cells with Tolerogenic Properties

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation

Effect of a novel immunosuppressant, ST1959, on the immune system and renal allograft survival in rats.

Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation

Effect of seliciclib (CYC202, R-roscovitine) on lymphocyte alloreactivity and acute kidney allograft rejection in rat.

Erythropoietin, but not the correction of anemia alone, protects from chronic kidney allograft injury

Extracellular vesicles derived from T regulatory cells suppress T cell proliferation and prolong allograft survival.

Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association

Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells

Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation

Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function

Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura

Immunophenotypic analysis of cellular infiltrate of renal allograft biopsies in patients with acute rejection after induction with alemtuzumab (Campath-1H).

Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes

Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.

Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion

Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis

Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)?

Klotho in acute kidney injury: biomarker, therapy, or a bit of both? ⬇️

L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species

MYO1E mutations and childhood familial focal segmental glomerulosclerosis

Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

More about Factor H Autoantibodies in Membranous Nephropathy

Mutations in FN1 cause glomerulopathy with fibronectin deposits.

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background

Overview of complement activation and regulation

Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension.

Prolonged cold ischemia accelerates cellular and humoral chronic rejection in a rat model of kidney allotransplantation ⬇️

Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides

Rabbit anti-rat thymocyte immunoglobulin preserves renal function during ischemia/reperfusion injury in rat kidney transplantation

Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS

Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Report of the First World Transplant Congress

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome

Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.

Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Terminal complement effectors in atypical hemolytic uremic syndrome: C5a, C5b-9, or a bit of both?

The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome

The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models

The role of complement in C3 glomerulopathy

The role of vasoactive molecules of endothelial origin in the pathophysiology of normal pregnancy and pregnancy-induced hypertension

Thrombotic Microangiopathies

Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes

Transplantation-Induced Ischemia-Reperfusion Injury Modulates Antigen Presentation by Donor Renal CD11c+F4/80+ Macrophages through IL-1R8 Regulation

Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN

Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity

Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy

Where next with atypical hemolytic uremic syndrome?

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome